SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vasisht Niraj

(Last)

(First)

(Middle)

C/O BIODELIVERY SCIENCES INTL, INC.,

4131 PARKLAKE AVE. SUITE 225

(Street)

RALEIGH

27612

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2016

3. Issuer Name and Ticker or Trading Symbol
BIODELIVERY SCIENCES INTERNATIONAL INC [ BDSI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & Chief Technology Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	67,420	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	05/29/2008	05/29/2017	Common Stock	33,500	$5.22	D
Options	10/01/2009	10/01/2018	Common Stock	20,000	$2.54	D
Options	01/21/2011	01/21/2020	Common Stock	17,686	$3.9	D
Options	07/21/2011	07/21/2020	Common Stock	17,329	$2.43	D
Options	01/25/2012	01/25/2021	Common Stock	25,000	$3.47	D
Options	02/25/2012	02/25/2021	Common Stock	12,105	$3.55	D
Options	02/09/2013	02/09/2022	Common Stock	24,579	$1.78	D
Options	02/15/2013	02/15/2022	Common Stock	14,297	$1.96	D
Restricted Stock Units	01/30/2016	01/30/2016	Common Stock	16,667	$0.00	D
Restricted Stock Units	02/20/2016	02/20/2016	Common Stock	27,666	$0.00	D
Restricted Stock Units	02/22/2016	02/22/2016	Common Stock	24,980	$0.00	D
Restricted Stock Units	02/23/2016	02/23/2016	Common Stock	66,667	$0.00	D
Restricted Stock Units	01/30/2017	01/30/2017	Common Stock	16,666	$0.00	D
Restricted Stock Units	02/22/2017	02/22/2017	Common Stock	24,980	$0.00	D
Restricted Stock Units	02/23/2017	02/23/2017	Common Stock	66,667	$0.00	D
Restricted Stock Units	02/23/2018	02/23/2018	Common Stock	66,666	$0.00	D

Explanation of Responses:

Remarks:

	/s/ Niraj Vasisht	01/08/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.